Programming Grants to Accompany NEH on the Road Exhibitions
Deadline : 11-9-2016
Funding Opportunity : RFA-HL-15-027
CFDA : 93.838|000000
Agency : Department of Health and Human Services
Contact : NIH OER Webmaster
Eligibility : Small businesses
This program will support the commercial development and validation of novel in vitro human cell-based tools for predicting the responses of individual patients to cystic fibrosis transmembrane conductance regulator (CFTR)-directed therapeutics for cystic fibrosis (CF) lung disease. NHLBI anticipates that outcomes of successful SBIR projects will help attract strategic partners or investors to support ultimate commercialization of a personalized medicine platform that could accelerate translation of CFTR-directed therapy in patients with CF lung disease.